Biotech company Visterra scores $46.7 mln Series C
Cambridge, Massachusetts-based Visterra Inc, a biotech company, has closed its Series C funding round at $46.7 million. The investors included the Bill & Melinda Gates Foundation, MRL Ventures Fund, Vertex Venture Holdings Ltd., Polaris Partners, Flagship Pioneering, Omega Funds, Cycad Group and Alexandria Venture Investments.
5 October 2017•4 mins read
